Ready 8-Ks
9
Latest filing
May 14, 2026, 5:11 PM ET
Top materiality
0.65
Event mix
other_material ×6 · earnings ×1 · debt ×1
Sentiment
1 pos · 1 neg · 7 neu
Recent 8-K filings for AURX
Highest-materiality recent filing
Nuo Therapeutics secures up to $1.6M loan with 10%-12% PIK interest paid in warrants; insider participation
- Loan agreement for $1.0M initial + $600K second tranche (Sept 30, 2026); $1.0M funded Jan 23, 2026.
- Interest 10% annual on initial note, rising to 12% if second tranche is taken; accrued interest paid only in warrants at maturity.
-
Nuo Therapeutics Q1 revenues up 169% YoY to $1.3M; operating loss narrows
Total revenue $1.3M, including $1.22M product sales, up 169% YoY and 20% sequential.
-
Loan agreement for $1.0M initial + $600K second tranche (Sept 30, 2026); $1.0M funded Jan 23, 2026.
-
Nuo Therapeutics dismisses auditor Marcum, engages MaloneBailey; cites material weaknesses
Effective June 7, 2024, dismissed Marcum LLP as independent auditor; engaged MaloneBailey, LLP for FY 2024.
Materiality & sentiment trend
Max materiality 0.65 · Median 0.40 · Most common event other_material